Viewing StudyNCT00426205



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00426205
Status: COMPLETED
Last Update Posted: 2022-02-11
First Post: 2007-01-23

Brief Title: GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Refractory CML Myeloid Blast Crisis
Myelodysplastic Syndrome RAEB-I or RAEB-II
Refractory Acute Myeloid Leukemia
Keywords:
Name View
GM-CSF View
GVAX View
Cancer vaccine View
blood stem cell transplantation View
MDS View
AML View
CML View